The French specialist pharma company Advicenne Pharma SA raised €27 million in an initial public offering (IPO) of its shares on the Paris Euronext exchange on 4 December to advance its pipeline of drugs for orphan renal and neurological diseases. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
